| EP3697914 - VECTORS FOR THE TREATMENT OF FRIEDREICH'S ATAXIA [Right-click to bookmark this link] | Status | No opposition filed within time limit Status updated on 12.04.2024 Database last updated on 28.03.2026 | |
| Former | The patent has been granted Status updated on 05.05.2023 | ||
| Former | Grant of patent is intended Status updated on 27.11.2022 | ||
| Former | Examination is in progress Status updated on 19.10.2022 | ||
| Former | Grant of patent is intended Status updated on 07.06.2022 | ||
| Former | Examination is in progress Status updated on 02.07.2021 | ||
| Former | Request for examination was made Status updated on 24.07.2020 | ||
| Former | The international publication has been made Status updated on 26.04.2019 | ||
| Former | unknown Status updated on 27.10.2018 | Most recent event Tooltip | 01.08.2025 | Lapse of the patent in a contracting state New state(s): CY | published on 03.09.2025 [2025/36] | Applicant(s) | For all designated states Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol Carretera de Can Ruti Camí de les Escoles, s/n 08916 Badalona / ES | For all designated states Gentec, S.A. Plaça d'Europa 9-11, 3B 08908 L'Hospitalet de Llobregat (Barcelona) / ES | [2023/19] |
| Former [2020/35] | For all designated states Fundació Institut d'Investigació en Ciències de la Salut Germans Trias i Pujol Carretera de Can Ruti Camí de les Escoles, s/n 08916 Badalona / ES | ||
| For all designated states Gentec, S.A. C. Tarragona, 161, pta. 18 08014 Barcelona / ES | Inventor(s) | 01 /
MATILLA DUEÑAS, Antoni Fundació Institut D'Investigació en Ciències de la Salut Germans Trias I Pujol Carretera de Can Ruti Camí de les Escoles s/n 08916 Badalona / ES | 02 /
SÁNCHEZ DÍAZ, Ivelisse Fundació Institut D'Investigació en Ciències de la Salut Germans Trias I Pujol Carretera de Can Ruti Camí de les Escoles s/n 08916 Badalona / ES | 03 /
BALAGUÉ CABASÉS, Eudald Fundació Institut D'Investigació en Ciències de la Salut Germans Trias I Pujol Carretera de Can Ruti Camí de les Escoles s/n 08916 Badalona / ES | [2020/35] | Representative(s) | Hoffmann Eitle Hoffmann Eitle S.L.U. Paseo de la Castellana 140, 3a planta Edificio LIMA 28046 Madrid / ES | [2020/35] | Application number, filing date | 18786778.3 | 17.10.2018 | [2020/35] | WO2018EP78384 | Priority number, date | EP20170382691 | 17.10.2017 Original published format: EP 17382691 | [2020/35] | Filing language | EN | Procedural language | EN | Publication | Type: | A1 Application with search report | No.: | WO2019076973 | Date: | 25.04.2019 | Language: | EN | [2019/17] | Type: | A1 Application with search report | No.: | EP3697914 | Date: | 26.08.2020 | Language: | EN | The application published by WIPO in one of the EPO official languages on 25.04.2019 takes the place of the publication of the European patent application. | [2020/35] | Type: | B1 Patent specification | No.: | EP3697914 | Date: | 07.06.2023 | Language: | EN | [2023/23] | Type: | B9 Corrected patent specification | No.: | EP3697914 | Date: | 04.10.2023 | [2023/40] | Search report(s) | International search report - published on: | EP | 25.04.2019 | Classification | IPC: | C12N15/86 | [2020/35] | CPC: |
C12N15/86 (EP,US);
A61K48/005 (US);
A61K48/0058 (US);
A61K48/0066 (US);
A61P25/00 (US);
A61P25/14 (US);
| Designated contracting states | AL, AT, BE, BG, CH, CY, CZ, DE, DK, EE, ES, FI, FR, GB, GR, HR, HU, IE, IS, IT, LI, LT, LU, LV, MC, MK, MT, NL, NO, PL, PT, RO, RS, SE, SI, SK, SM, TR [2020/35]
| Extension states | BA | Not yet paid | ME | Not yet paid | Validation states | KH | Not yet paid | MA | Not yet paid | MD | Not yet paid | TN | Not yet paid | Title | German: | VEKTOREN ZUR BEHANDLUNG DER FRIEDREICH-ATAXIE | [2020/35] | English: | VECTORS FOR THE TREATMENT OF FRIEDREICH'S ATAXIA | [2020/35] | French: | VECTEURS DESTINÉS AU TRAITEMENT DE L'ATAXIE DE FRIEDREICH | [2022/23] |
| Former [2020/35] | VECTEURS POUR LE TRAITEMENT DE L'ATAXIE DE FRIEDREICH | Entry into regional phase | 13.05.2020 | National basic fee paid | 13.05.2020 | Designation fee(s) paid | 13.05.2020 | Examination fee paid | Examination procedure | 16.08.2019 | Request for preliminary examination filed International Preliminary Examining Authority: EP | 13.05.2020 | Examination requested [2020/35] | 13.05.2020 | Date on which the examining division has become responsible | 04.12.2020 | Amendment by applicant (claims and/or description) | 06.07.2021 | Despatch of a communication from the examining division (Time limit: M02) | 16.09.2021 | Reply to a communication from the examining division | 08.06.2022 | Communication of intention to grant the patent | 17.10.2022 | Disapproval of the communication of intention to grant the patent by the applicant or resumption of examination proceedings by the EPO | 28.11.2022 | Communication of intention to grant the patent | 24.03.2023 | Fee for grant paid | 24.03.2023 | Fee for publishing/printing paid | 24.03.2023 | Receipt of the translation of the claim(s) | Divisional application(s) | EP22170787.0 / EP4089173 | Opposition(s) | 08.03.2024 | No opposition filed within time limit [2024/20] | Fees paid | Renewal fee | 19.10.2020 | Renewal fee patent year 03 | 18.10.2021 | Renewal fee patent year 04 | 18.10.2022 | Renewal fee patent year 05 |
| Opt-out from the exclusive Tooltip competence of the Unified Patent Court | See the Register of the Unified Patent Court for opt-out data | ||
| Responsibility for the accuracy, completeness or quality of the data displayed under the link provided lies entirely with the Unified Patent Court. | Lapses during opposition Tooltip | CY | 17.10.2018 | HR | 07.06.2023 | MC | 07.06.2023 | SM | 07.06.2023 | [2025/36] |
| Former [2024/28] | HR | 07.06.2023 | |
| MC | 07.06.2023 | ||
| SM | 07.06.2023 | ||
| Former [2024/08] | HR | 07.06.2023 | |
| SM | 07.06.2023 | ||
| Former [2023/51] | HR | 07.06.2023 | Cited in | International search | [YD] WO2016150964 (INSERM (INSTITUT NAT DE LA SANTÉ ET DE LA RECH MÉDICALE) et al.) | [Y] WO2016115503 (VOYAGER THERAPEUTICS INC et al.) | [Y] WO2009034127 (INST NAT SANTE RECH MED et al.) | [Y] REZAIE E S ET AL: "Intra-luminal gene therapy in the porcine artery using a recombinant adeno-associated virus 9", GENE., vol. 618, 1 June 2017 (2017-06-01), NL, pages 24 - 27, XP055496994, ISSN: 0378-1119, DOI: 10.1016/j.gene.2017.03.019 DOI: http://dx.doi.org/10.1016/j.gene.2017.03.019 | [Y] MATTAR C N ET AL: "Systemic gene delivery following intravenous administration of AAV9 to fetal and neonatal mice and late-gestation nonhuman primates", THE FASEB JOURNAL, vol. 29, no. 9, 1 September 2015 (2015-09-01), US, pages 3876 - 3888, XP055496998, ISSN: 0892-6638, DOI: 10.1096/fj.14-269092 DOI: http://dx.doi.org/10.1096/fj.14-269092 | by applicant | WO2016150964 | GERARD ET AL., MOL THER METHODS CLIN DEV, vol. 1, 2014, pages 14044 | CHAPDELAINE ET AL., GENE THER, vol. 23, no. 7, 2016, pages 606 - 614 | TREMBLAY ET AL., MOL THER., vol. 23, no. 1, 2015, pages S153 | ALTSCHUL ET AL., J MOL BIOL., vol. 215, no. 3, 1990, pages 403 - 10 | "Remington's Pharmaceutical Sciences", 1980 | POOK ET AL., NEUROGENETICS, vol. 3, no. 4, 2001, pages 185 - 93 | VIRMOUNI ET AL., PLOS ONE, vol. 9, no. 9, 2014, pages e107416 |